Hou et al. propose a model whereby PRC2 and NuRD complexes are recruited by PHF20L1 binding to H3K27me2, resulting in transcriptional repression in the context of breast tumorigenesis (70). This evidence concerns the gene PHF20L1 and medical procedure.